ABLE Labs Secures $12 Billion in Latest Series A Funding Round

ABLE Labs secured $12 billion in its latest Series A, adding another data point to the FinTech funding market.

ABLE Labs Raises $12 billion in Funding

<strongThe company is currently finalizing a Series A financing round exceeding KRW 10 billion (approximately USD 6.8 million)</strong and is conducting a proof-of-concept (PoC) project with a major U.S. ABLE Labs. Company Profile & Funding. ABLE Labs is to contribute improve human health by providing bio automated solutions.

Investors Behind the Funding

The round was backed by Big Pharma PoC this year < ENGLISH NEWS < 기사본문 - 더바이오. Capvizr tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.

Company Profile and Market Context

ABLE Labs operates in FinTech. ABLE Labs's financing adds to recent private-market activity.

Strategic Use of Funds

Contribute improve human health by providing bio automated solutions.

Looking Ahead

ABLE Labs raises 12.1B KRW Series A for lab automation push

Source reference: original announcement/article.